REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Max Pharma S.R.O. (Czech Republic)

Main Activities: Chemical Manufacturing
Full name: Dr. Max Pharma S.R.O. Profile Updated: November 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Dr. Max Pharma S.R.O. is an enterprise located in Czech Republic, with the main office in Prague. It operates in the Chemical Manufacturing industry. The company was established on May 03, 2016. It currently has a total number of 50 - 99 (2023) employees. From the latest financial highlights, Dr. Max Pharma S.R.O. reported a net sales revenue increase of 24.1% in 2022. Its’ total assets recorded a growth of 85.31%. Dr. Max Pharma S.R.O.’s net profit margin decreased by 0.14% in 2022.

Headquarters
Na Florenci 2116/15
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Dr. Max Pharma S.R.O. report to view the information.

Website: http://www.drmaxpharma.com

Basic Information
Total Employees:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr. Max Pharma S.R.O. report to view the information.
Incorporation Date:
May 03, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr. Max Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
24.1%
Total operating revenue
19.57%
Operating profit (EBIT)
-38.85%
EBITDA
-19.86%
Net Profit (Loss) for the Period
13.93%
Total assets
85.31%
Total equity
5.46%
Operating Profit Margin (ROS)
-2.1%
Net Profit Margin
-0.14%
Return on Equity (ROE)
0.39%
Debt to Equity Ratio
-0.08%
Quick Ratio
-0.37%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?